Indivior backs FY25 revenue view $955M-$1.03B, consensus $1.02B

Backs FY25 gross margin view low- to mid-80s percent range. Backs FY25 operating income view $185M-$225M. The company said, “Guidance also assumes no material change to Medicaid eligibility policy and/or other changes to Federal funding levels due to executive actions. Guidance also does not include any potential impacts from tariffs imposed by the U.S. government or any retaliatory tariffs that may be imposed by other countries.”